Structured evidence table for Matcha Cognitive Performance Meta-Analysis, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Matcha Cognitive Performance Meta-Analysis | Background/Objectives : Mood disorders include symptoms of depression, anxiety, and or stress, and have increased in prevalence. | 1 | Cavanah AM (2025) | The Impact of Green Tea and Its Bioactive Compounds on Mood Disorder Symptomology and Brain Derived Neurotrophic Factor: A Systematic Review of Randomized Controlled Trials. |
| Matcha Cognitive Performance Meta-Analysis | This study aimed to assess current evidence from published randomized controlled trials testing the effects of green tea, green tea extracts, or its bioactive compounds on mood disorder symptomology and brain-derived neurotrophic factor (BDNF). | 1 | Cavanah AM (2025) | The Impact of Green Tea and Its Bioactive Compounds on Mood Disorder Symptomology and Brain Derived Neurotrophic Factor: A Systematic Review of Randomized Controlled Trials. |
| Matcha Cognitive Performance Meta-Analysis | Seven used one of the bioactive compounds found in green tea for intervention, while six used green tea extract, matcha, or traditional green tea. | 1 | Cavanah AM (2025) | The Impact of Green Tea and Its Bioactive Compounds on Mood Disorder Symptomology and Brain Derived Neurotrophic Factor: A Systematic Review of Randomized Controlled Trials. |
| Matcha Cognitive Performance Meta-Analysis | Green tea and its bioactive components (epigallocatechin gallate [EGCG] and L-theanine) have been investigated for their health benefits and neuroprotective properties. | 1 | Cavanah AM (2025) | The Impact of Green Tea and Its Bioactive Compounds on Mood Disorder Symptomology and Brain Derived Neurotrophic Factor: A Systematic Review of Randomized Controlled Trials. |
Source documents